Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

NCT00032799 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

905

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: natalizumab

Sponsor

Biogen

Collaborators

[object Object]